Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NNC-55-0118 characterized as beta-cell-selective potassium channel opener

Sep. 30, 2002

AP-23588 exerts both antiresorptive and bone formation-enhancing effects

Sep. 30, 2002

Potent, selective EP4 agonists identified at Pfizer, effective in osteopenic rat model

Sep. 30, 2002

Preclinical data support use of KRN-1493 in secondary hyperparathyroidism

Sep. 30, 2002

Small-molecule inhibitor of RANK-RANKL interaction presented at ASBMR meeting

Sep. 30, 2002

PT-141 shows phase I potential for female sexual dysfunction

Sep. 30, 2002

Bone-targeted Src tyrosine kinase inhibitor may have use in bone metastases

Sep. 30, 2002

ERbeta agonist isolated from plant by Merck researchers

Sep. 30, 2002

Bone loss in inflammatory arthritis prevented by CLX-0921 and etanercept

Sep. 27, 2002

LDL receptor upregulators covered by Takeda patent

Sep. 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...